Constantinos E. Vorgias

Dr. Constantinos E. Vorgias


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AGAnastasios Georgoulis
Anastasios Georgoulis
CVConstantinos E. Vorgias
Constantinos E. Vorgias
George P. ChrousosGeorge P. Chrousos
George P. Chrousos
EREmmy P. Rogakou
Emmy P. Rogakou
γH2AX has emerged in the last 20 years as a central player in the DDR (DNA damage response), with specificity for DSBs (double-strand breaks). Upon the generation of DSBs, γ-phosphorylation extends along megabase-long domains in chromatin, both sides of the damage. The significance of this mechanism is of great importance; it depicts a biological amplification mechanism where one DSB induces the γ-phosphorylation of thousands of H2AX molecules along megabaselong domains of chromatin, that are adjusted to the sites of DSBs. A sequential recruitment of signal transduction factors that interact to each other and become activated to further amplify the signal that will travel to the cytoplasm take place on the γ-phosphorylated chromatin. γ-phosphorylation is an early event in the DSB damage response, induced in all phases of the cell cycle, and participates in both DSB repair pathways, the HR (homologous recombination) and NHEJ (non-homologous end joining). Today, numerous studies support the notion that γH2AX functions as a guardian of the genome by preventing misrepaired DSB that increase the mutation load of the cells and may further lead to genome instability and carcinogenesis.

26 August 2005
Verified
Book Chapter
Closed access
PDF file
GAGarabed Antranikian
Garabed Antranikian
CVConstantinos E. Vorgias
Constantinos E. Vorgias
CBCostanzo Bertoldo
Costanzo Bertoldo




1 January 2020 in Redox Biology
Verified
Journal Article
Open access
MLMaria Lefaki
Maria Lefaki
NPNikoletta Papaevgeniou
Nikoletta Papaevgeniou
Josep TurJosep Tur
Josep Tur
CVConstantinos E. Vorgias
Constantinos E. Vorgias
Gerasimos SykiotisGerasimos Sykiotis
Gerasimos Sykiotis
Niki ChondrogianniNiki Chondrogianni
Niki Chondrogianni
18 alpha-Glycyrrhetinic acid (18 alpha-GA) is a bioactive triterpenoid that has been shown to activate the nuclear factor (erythroid-derived-2)-like 2 (Nrf2), the main transcription factor that orchestrates the cellular antioxidant response, in both cellular and organismal context. Although various beneficial properties of 18 alpha-GA have been revealed, including its anti-oxidation and anti-aging activity, its possible protective effect against DNA damage has never been addressed. In this study, we investigated the potential beneficial properties of 18 alpha-GA against DNA damage induced by mitomycin C (MMC) treatment. Using human primary fibroblasts exposed to MMC following pre-treatment with 18 alpha-GA, we reveal an Nrf2-mediated protective effect against MMC-induced cell death that depends on extracellular signal-regulated kinase (ERK) signaling. In total, our results reveal an additional beneficial effect of the Nrf2 activator 18 alpha-GA, suggesting that this important phytochemical compound is a potential candidate in preventive and/or therapeutic schemes against conditions (such as aging) or diseases that are characterized by both oxidative stress and DNA damage.